Skip to main content

Table 3 The enriched KEGG pathway terms of the DEGs

From: Key genes with prognostic values in suppression of osteosarcoma metastasis using comprehensive analysis

Pathway IDPathway NameGene CountFDRLogPGenes
hsa05150Staphylococcus aureus infection106.33E-13−15.21HLA-DQB1, C1QA, HLA-DRB4, HLA-DPA1, FCGR2A, HLA-DMB, HLA-DOA, HLA-DMA, HLA-DQA1, HLA-DRA
hsa05332Graft-versus-host disease91.37E-12−14.85HLA-DQB1, CD86, HLA-DRB4, HLA-DPA1, HLA-DMB, HLA-DOA, HLA-DMA, HLA-DQA1, HLA-DRA
hsa05330Allograft rejection93.67E-12−14.41HLA-DQB1, CD86, HLA-DRB4, HLA-DPA1, HLA-DMB, HLA-DOA, HLA-DMA, HLA-DQA1, HLA-DRA
hsa04940Type I diabetes mellitus91.11E-11−13.93HLA-DQB1, CD86, HLA-DRB4, HLA-DPA1, HLA-DMB, HLA-DOA, HLA-DMA, HLA-DQA1, HLA-DRA
hsa04672Intestinal immune network for IgA production92.96E-11−13.50HLA-DQB1, CD86, HLA-DRB4, HLA-DPA1, HLA-DMB, HLA-DOA, HLA-DMA, HLA-DQA1, HLA-DRA
hsa05322Systemic lupus erythematosus113.85E-11−13.39HLA-DQB1, C1QA, CD86, HLA-DRB4, HLA-DPA1, FCGR2A, HLA-DMB, HLA-DOA, HLA-DMA, HLA-DQA1, HLA-DRA
hsa05320Autoimmune thyroid disease97.06E-11−13.13HLA-DQB1, CD86, HLA-DRB4, HLA-DPA1, HLA-DMB, HLA-DOA, HLA-DMA, HLA-DQA1, HLA-DRA
hsa05310Asthma81.49E-10−12.80HLA-DQB1, HLA-DRB4, HLA-DPA1, HLA-DMB, HLA-DOA, HLA-DMA, HLA-DQA1, HLA-DRA
hsa05416Viral myocarditis91.54E-10−12.79HLA-DQB1, CD86, HLA-DRB4, HLA-DPA1, HLA-DMB, HLA-DOA, HLA-DMA, HLA-DQA1, HLA-DRA
hsa05152Tuberculosis116.54E-10−12.16HLA-DQB1, HLA-DRB4, HLA-DPA1, FCGR2A, HLA-DMB, HLA-DOA, HLA-DMA, CD14, CD74, HLA-DQA1, HLA-DRA
hsa05140Leishmaniasis99.79E-10−11.98HLA-DQB1, HLA-DRB4, HLA-DPA1, FCGR2A, HLA-DMB, HLA-DOA, HLA-DMA, HLA-DQA1, HLA-DRA
hsa04612Antigen processing and presentation91.73E-09−11.74HLA-DQB1, HLA-DRB4, HLA-DPA1, HLA-DMB, HLA-DOA, HLA-DMA, CD74, HLA-DQA1, HLA-DRA
hsa05323Rheumatoid arthritis95.81E-09−11.21HLA-DQB1, CD86, HLA-DRB4, HLA-DPA1, HLA-DMB, HLA-DOA, HLA-DMA, HLA-DQA1, HLA-DRA
hsa04145Phagosome108.33E-09−11.06HLA-DQB1, HLA-DRB4, HLA-DPA1, FCGR2A, HLA-DMB, HLA-DOA, HLA-DMA, CD14, HLA-DQA1, HLA-DRA
hsa05145Toxoplasmosis93.62E-08−10.42HLA-DQB1, HLA-DRB4, HLA-DPA1, ALOX5, HLA-DMB, HLA-DOA, HLA-DMA, HLA-DQA1, HLA-DRA
hsa05321Inflammatory bowel disease (IBD)84.36E-08−10.34HLA-DQB1, HLA-DRB4, HLA-DPA1, HLA-DMB, HLA-DOA, HLA-DMA, HLA-DQA1, HLA-DRA
hsa04514Cell adhesion molecules (CAMs)92.86E-07−9.52HLA-DQB1, CD86, HLA-DRB4, HLA-DPA1, HLA-DMB, HLA-DOA, HLA-DMA, HLA-DQA1, HLA-DRA
hsa05168Herpes simplex infection92.18E-06−8.64HLA-DQB1, HLA-DRB4, HLA-DPA1, HLA-DMB, HLA-DOA, HLA-DMA, CD74, HLA-DQA1, HLA-DRA
hsa05164Influenza A85.24E-05−7.26HLA-DQB1, HLA-DRB4, HLA-DPA1, HLA-DMB, HLA-DOA, HLA-DMA, HLA-DQA1, HLA-DRA
hsa05166HTLV-I infection87.01E-04−6.13HLA-DQB1, HLA-DRB4, HLA-DPA1, HLA-DMB, HLA-DOA, HLA-DMA, HLA-DQA1, HLA-DRA
hsa05169Epstein-Barr virus infection50.13728−3.84HLA-DQB1, HLA-DRB4, HLA-DPA1, HLA-DQA1, HLA-DRA
hsa04640Hematopoietic cell lineage314.8897−1.77HLA-DRB4, CD14, HLA-DRA